Logo Image
|Articles|September 9, 2014

The Nordic Region’s “Star” Companies

Three companies were crowned the Nordic region’s “shining examples of innovative life science companies” in Stockholm, Sweden, this week.

Three companies were crowned the Nordic region’s “shining examples of innovative life science companies” in Stockholm, Sweden, this week.  Nordic Life Science Days, the region’s largest partnering conference, gave its annual Nordic Star Awards to Bone Index (Kuopio, Finland), Lytix Biopharma (Oslo, Norway) and PledPharma (Stockholm, Sweden).

Bone Index was noted for its osteoporosis diagnostic, Bindex, while Lytix Biopharma was rewarded for its results in the field of immuno-oncology. PledPharma was praised for its clinical project platform that targets significant medical needs.

Related to this article

View more
Pharmaceutical Executive Daily
Pharmaceutical Executive Daily: Nxera Licenses EP4 Agonist to AbbVie
How microgravity is opening new possibilities for drug R&D and manufacturing, a pharma funding roundup covers Boehringer Ingelheim’s up-to-$7 billion oncology licensing deal with Sino Biopharmaceutical and Nxera Pharma’s EP4 agonist deal with AbbVie, and CytoDyn’s Dr. Jay Lalezari on why Leronlimab isn’t just another repurposed drug.
Read more
The Promise of Microgravity for R&D and Manufacturing
The Promise of Microgravity for R&D and Manufacturing
As access to low Earth orbit expands, space-based research is opening possibilities in drug discovery, formulation, and manufacturing. In Part 1, the authors look at how microgravity changes biology and chemistry in ways that can’t be reproduced on Earth and where it fits from target discovery to life cycle management.
Read more